Clinical Study on Effect of Common Methylenetetrahydrofolate Reductase Gene Mutation on Coronary Artery Disease in Hypertension

牛杰,张喆,陈明哲,王广,毛节明,郭静萱,李伟联,王宪
DOI: https://doi.org/10.3969/j.issn.1004-8812.2005.01.008
2005-01-01
Abstract:Objective To investigate the association between the MTHFR gene C677T mutation and CAD in patients with hypertension. Methods Of the 103 cases of patients with hypertension who underwent coronary angiography, 58 were CAD and 45 were not. MTHFR genotypes were identified by PCR and restriction fragment length polymorphism analysis with Hinf I digestion. Plasma folate was determined by radioimmunoassay. Plasma HCY was determined by HPLC. Results The frequencies of T677 allele (0.45) in the CAD group were markedly higher than those in the control group (0.33, P=0.03), plasma homocysteine level in the CAD group (17.73±2.22 μmol/L) was also significantly higher than that in the control group (12.18±1.23 μmol/L, P=0.037). There was no significant difference in the concentrations of folate for the two studied groups. Conclusion The MTHFR gene T677 variant is the genetic high risk factor for CAD in patients with hypertension. It can induce the hyperhomocysteinemia, potentially contributing to the pathogeny of CAD.
What problem does this paper attempt to address?